Blaustein J D, Brown T J
Brain Res. 1984 Jun 25;304(2):225-36. doi: 10.1016/0006-8993(84)90325-1.
In a study of cellular mechanisms of progesterone's antiestrogenic action on behavior and neuroendocrine responses, we investigated the influence of progesterone on the concentration of estrogen receptors in the hypothalamus-preoptic area (HP), anterior pituitary gland (AP), and uterus of chronically estradiol-treated ovariectomized rats. Ovariectomized (OVX) rats were implanted s.c. with 15 mm silastic capsules of estradiol. One week later, they were injected with progesterone or oil vehicle and killed 6 h or 24 h later. Confirming previous reports, progesterone caused a decrease in the concentration of uterine cytosol and nuclear estrogen receptors at both times. Less consistent results were obtained in HP and AP; a decrease in the concentration of HP cytosol estrogen receptors was detected at 6 h, as was a small decrease in the concentration of HP nuclear estrogen receptors at 24 h. More consistent results were seen when a low priming dose of estradiol was used. Although progesterone was without effect on the concentration of nuclear estrogen receptors in HP and AP at 6 h, cytosol receptor levels were depressed by 25% in HP and 14% in AP. At 24 h after progesterone injection, nuclear estrogen receptor levels were decreased in all tissues, while cytosol estrogen receptor levels remained depressed. A study of the time course of progesterone's suppression of cytosol estrogen receptor concentration revealed that the effect is transient, occurring by 6 h after progesterone injection, but returning to baseline by 48 h after injection. Scatchard analysis confirmed that the decreased concentration of cytosol binding in HP was due to a decrease in the concentration of binding sites. As with nearly all of progesterone's neuroendocrine effects, the suppression of estrogen receptor levels requires estrogen priming. HP and AP cytosol from progesterone-treated rats did not seem to contain an estrogen receptor-regulatory factor as do uterine cell nuclei; loss of binding sites at 37 degrees C was no faster in cytosol from progesterone-treated rats. These results demonstrate that, under some conditions, progesterone decreases HP and AP estrogen receptor concentrations. Unlike progesterone's action in the uterus, the primary effect in the brain and pituitary gland seems to be on the cytosol receptor.
在一项关于孕酮对行为和神经内分泌反应的抗雌激素作用的细胞机制研究中,我们调查了孕酮对长期接受雌二醇处理的去卵巢大鼠下丘脑视前区(HP)、垂体前叶(AP)和子宫中雌激素受体浓度的影响。去卵巢(OVX)大鼠皮下植入含15 mm雌二醇的硅橡胶胶囊。一周后,给它们注射孕酮或油性载体,并在6小时或24小时后处死。正如先前报道所证实的,孕酮在这两个时间点均导致子宫胞浆和核雌激素受体浓度降低。在HP和AP中获得的结果不太一致;在6小时时检测到HP胞浆雌激素受体浓度降低,在24小时时HP核雌激素受体浓度也有小幅降低。当使用低剂量的雌二醇启动时,观察到更一致的结果。尽管孕酮在6小时时对HP和AP中的核雌激素受体浓度没有影响,但HP中的胞浆受体水平降低了25%,AP中的降低了14%。在注射孕酮24小时后,所有组织中的核雌激素受体水平均降低,而胞浆雌激素受体水平仍处于抑制状态。一项关于孕酮抑制胞浆雌激素受体浓度的时间进程研究表明,这种作用是短暂的,在注射孕酮后6小时出现,但在注射后48小时恢复到基线水平。Scatchard分析证实,HP中胞浆结合浓度的降低是由于结合位点浓度的降低。与孕酮几乎所有的神经内分泌作用一样,雌激素受体水平的抑制需要雌激素启动。孕酮处理大鼠的HP和AP胞浆似乎不像子宫细胞核那样含有雌激素受体调节因子;在37℃下,孕酮处理大鼠胞浆中结合位点的丧失并不更快。这些结果表明,在某些条件下,孕酮会降低HP和AP中的雌激素受体浓度。与孕酮在子宫中的作用不同,在脑和垂体中的主要作用似乎是对胞浆受体的作用。